Credo Diagnostics Biomedical Pte. Ltd., a groundbreaking point-of-care rapid molecular diagnostic company, announced today they will attend the Medlab Middle East exhibition that will take place at the Dubai World Trade Centre from February 3 to February 6.
Credo Diagnostics Biomedical will be showcasing it product line of point-of-care molecular diagnostic solution including the VitaPCR™ platform and Influenza A&B assay, the new QubeMDx+ platform and assays, as well as the upcoming fastest auto-extractor in the world, the Purexon.
Credo Diagnostics Biomedical will be located at the booth #Z4.D29, where they will be meeting with individual practitioners, laboratory technicians, scholars, and potential business partners.
Expanding Companion Animal Molecular Diagnostics for Emerging Infectious Disease Challenges
Credo Diagnostics Biomedi